Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial
出版年份 2016 全文链接
标题
Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial
作者
关键词
Exenatide, Glycemic variations, Insulin doses, Type 2 diabetes
出版物
Diabetes Therapy
Volume 8, Issue 1, Pages 177-187
出版商
Springer Nature
发表日期
2016-12-19
DOI
10.1007/s13300-016-0222-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists Utilizing Data from the Exenatide Clinical Trial Development Program
- (2016) Hui Peng et al. Current Diabetes Reports
- Glucose Variability in a 26-Week Randomized Comparison of Mealtime Treatment With Rapid-Acting Insulin Versus GLP-1 Agonist in Participants With Type 2 Diabetes at High Cardiovascular Risk
- (2016) DIABETES CARE
- Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy
- (2016) A. Dutour et al. DIABETES OBESITY & METABOLISM
- The establishment of biological reference intervals of nontraditional glycemic markers in a Chinese population
- (2016) Qiang Zhou et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- GLP1-RA Add-on Therapy in Patients with Type 2 Diabetes Currently on a Bolus Containing Insulin Regimen
- (2016) Marie L. Davies et al. PHARMACOTHERAPY
- Comparison of exenatide with biphasic insulin aspart 30 on glucose variability in type 2 diabetes: study protocol for a randomized controlled trial
- (2016) Shaoyong Xu et al. Trials
- The Efficacy and Tolerability of Exenatide in Comparison to Placebo; A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2016) Shekoufeh Nikfar et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- β Cell Dysfunction Versus Insulin Resistance in the Pathogenesis of Type 2 Diabetes in East Asians
- (2015) Daisuke Yabe et al. Current Diabetes Reports
- Glucose Variability and β- Cell Response by GLP-1 Analogue added-on CSII for Patients with Poorly Controlled Type 2 Diabetes
- (2015) Chia-Hung Lin et al. Scientific Reports
- Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists
- (2015) Annachiara Uccellatore et al. Diabetes Therapy
- Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists
- (2015) Annachiara Uccellatore et al. Diabetes Therapy
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2014) Silvio E. Inzucchi et al. DIABETES CARE
- Ethnic-Specific Obesity Cutoffs for Diabetes Risk: Cross-sectional Study of 490,288 UK Biobank Participants
- (2014) Uduakobong E. Ntuk et al. DIABETES CARE
- Differences in the HbA1c-lowering efficacy of glucagon-like peptide-1 analogues between Asians and non-Asians: a systematic review and meta-analysis
- (2014) Y. G. Kim et al. DIABETES OBESITY & METABOLISM
- Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis
- (2014) Conrad Eng et al. LANCET
- Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes
- (2013) John B. Buse et al. ANNALS OF INTERNAL MEDICINE
- ProAct Study: New Features of Insulin Pumps Improve Diabetes Management and Glycemic Control in Patients after Transition of Continuous Subcutaneous Insulin Infusion Systems
- (2013) Ralph Ziegler et al. Diabetes Technology & Therapeutics
- Efficacy, Safety, and Tolerability of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus: An Integrated Analysis of the DURATION Trials
- (2013) Michael Grimm et al. POSTGRADUATE MEDICINE
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- Exenatide Improves Glycemic Variability Assessed by Continuous Glucose Monitoring in Subjects with Type 2 Diabetes
- (2011) Concetta Irace et al. Diabetes Technology & Therapeutics
- Effect of Exenatide on Inflammatory and Oxidative Stress Markers in Patients with Type 2 Diabetes Mellitus
- (2011) Jin-dan Wu et al. Diabetes Technology & Therapeutics
- The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a review
- (2011) Vanita R. Aroda et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Pharmacological management of type 2 diabetes: the potential of incretin-based therapies
- (2010) B. Charbonnel et al. DIABETES OBESITY & METABOLISM
- Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes
- (2010) A. H. Barnett et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- A Meta-Analysis of Placebo-Controlled Clinical Trials Assessing the Efficacy and Safety of Incretin-Based Medications in Patients with Type 2 Diabetes
- (2010) Walid K.H. Fakhoury et al. PHARMACOLOGY
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2008) D. M. Nathan et al. DIABETES CARE
- Intensive insulin therapy in newly diagnosed type 2 diabetes
- (2008) Ravi Retnakaran et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More